Sleep Number (SNBR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
12 May, 2026Executive summary
Net sales for Q1 2026 were $319 million, down 19% year-over-year, reflecting lower demand and reduced store count.
Adjusted EBITDA was $5.8 million to $6 million, ahead of internal plan but down significantly from the prior year.
Net loss widened to $50 million ($2.19 per share), compared to $9 million ($0.38 per share) in Q1 2025, driven by lower sales and higher restructuring costs.
The company is advancing a turnaround strategy focused on product and brand reset, cost savings, and capital structure solutions, including the "Sleep Number Shifts" initiative.
Early positive metrics from new product launches and marketing campaigns, with improved customer satisfaction and engagement.
Financial highlights
Gross profit margin was 57.9%, down from 61.2% year-over-year, mainly due to product mix shift and legacy inventory discounting.
Adjusted operating expenses before restructuring were $195 million, down 18% year-over-year.
Adjusted EBITDA margin fell to 1.8%, down 380 basis points year-over-year.
Free cash flow was a use of $13.2 million, worse than last year but better than expectations.
Operating loss was $37 million, compared to $2 million operating income in Q1 2025.
Outlook and guidance
No forward-looking financial guidance provided due to ongoing strategic and financing review.
Q2 net sales expected to be down low single digits to flat year-over-year.
Management expresses substantial doubt about the company's ability to continue as a going concern due to anticipated non-compliance with credit covenants beyond July 2026.
Ongoing actions include executing the turnaround strategy, engaging with lenders, and seeking additional capital or strategic alternatives.
Continued conservative planning due to consumer uncertainty and macro volatility.
Latest events from Sleep Number
- Shareholders to vote on board declassification, equity plan expansion, and governance reforms.SNBR
Proxy filing8 Apr 2026 - Proxy seeks board declassification, equity plan expansion, and governance modernization.SNBR
Proxy filing24 Mar 2026 - Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation12 Mar 2026 - Cost savings and new products drive turnaround, setting up double-digit EBITDA growth for 2026.SNBR
Q4 202512 Mar 2026 - Gross margin and cost improvements offset sales declines, supporting full-year EBITDA guidance.SNBR
Q2 20242 Feb 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 202417 Jan 2026 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 202613 Jan 2026 - Transformation plan targets growth, efficiency, and strong free cash flow in 2026.SNBR
Investor presentation13 Jan 2026 - Gross margin gains and cost cuts drove Q4 EBITDA up 43% despite double-digit sales declines.SNBR
Q4 202425 Dec 2025